The Ministry of Education and Science has chosen a project of the School of Pharmacy of the University of Navarra which studies intelligent biomaterials, for participation in the National Plan for Scientific Research, Development and Technological Innovation.
The project “NANOFAR: Preparation and characterization of new nanostructured materials for the controlled release of medications” involves research on nanotechnology as applied to the development of medications. Its purpose is the development of “intelligent biomaterials,” able to pass the cell membrane that normally impedes access of drugs to the target cell.
These materials increase the capacity to attack only diseased cells without damaging healthy ones. That is, they permit the design of highly selective drugs with very low toxicity.
In addition, these materials make possible the liberation of the therapeutic agent in a sustained manner over time, without the necessity to administer the drug repeatedly. The project intends to demonstrate the effectiveness of nanomedicine in the treatment of infectious diseases such as brucellosis, via a strategy that could potentially be applied to other diseases, such as cancer.
NANOFAR is a collaborative research project involving three groups: the special research line in Nanotechnologies and Controlled Drug Release, part of the Department of Pharmacy and Pharmaceutical Technology of the University of Navarra; the Molecular Nanoscience and Organic Materials Group of the Institute of Material Sciences of Barcelona (CSIC), of the Autonomous University of Barcelona; and the Group for Design, Synthesis and Structure of Peptides and Proteins of the Institute of Biomedical Research of Barcelona.English translation by: WORDLAN email@example.com; 615740862.